Medicago, a Quebec-based biopharmaceutical company, said it has produced a virus-like particle of the novel coronavirus, a first step to producing a vaccine.The isolated particle will now undergo pre-clinical safety and efficacy.
Emergent Biosolutions has initiated development of two product candidates, using its hyperimmune platforms that have a well-established safety database, for the treatment and prevention of coronavirus disease (COVID-19).
Brandon University is upgrading its Micro-analytical facility with the help of the Government of Canada
ImmuniMed Inc. received Canadian and U.S. regulatory approval more than two years ago for a novel treatment for C. diff. (Clostridioides difficile) the number one healthcare acquired superbug.
Natural Products Canada (NPC) is pleased to announce its investment in NovoBind Livestock Technologies (Novobind).
The project will help farmers become more efficient and achieve higher returns while improving traceability along the value chain.
Kane Biotech Inc. announced the launch of its silkstem™ anti-itch shampoo at the Global Pet Expo taking place on February 26-28, 2020.
Western Economic Diversification Canada (WD) is making strategic investments in key economic sectors and also supports the development of leading industry geographic clusters through its Business Scale-up and Productivity (BSP) program.
The coronavirus outbreak in China is hitting economies around the globe, including Winnipeg.
The Manitoba government is investing more than $2.4 million over four years for three applied research projects to enhance real-time access to the data health-care providers need to make informed decisions for patients, announced Minister Friesen
BioTalent Canada announced a new wage subsidy program to help youth facing challenges to employment gain valuable experience in Canada’s growing bio-economy.
The consortium would "provide with advice about where we should be in terms of production, processing, genetics and marketing, added Minister Pederson”
Manitoba Protein Consortium, to provide leadership on projects of strategic importance and encourage stakeholders to continue actions to implement the Manitoba Protein Advantage strategy.
With about 70 patents, series of fundings, and an innovative product line, primarily to address the prevention and removal of microbial biofilms, finally the 19-year-old company makes it big in the bioscience industry!
The project aims to improve quality of canola meal, making it more suitable for higher value markets
The Innovation Proof-of-Concept Grant aims to strengthen Manitoba-based research innovation and development projects.
Protein Industries Canada announced their second co-investment into a consortium-led project.The $19.1 million project will work to commercialize high quality plant-based proteins, focusing on proprietary pea protein and canola protein isolates.
Recent research has indicated that the persistence of microbial biofilm may be linked with aggravating the symptoms associated with atopic dermatitis, seborrheic dermatitis (also known as eczema) and dandruff. Kane Biotech’s shampoo consists of coactiv+TM
Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms
Trouble falling asleep? A local brewery may have the answer
The speech from the throne reaffirms the government’s 100-Day Action Plan and the five-point Moving Manitoba Forward Guarantee that will provide lower taxes for families, create 40,000 new private-sector jobs....
Medicago, a Quebec-based biopharmaceutical company, said it has produced a virus-like particle of the novel coronavirus, a first step to producing a vaccine.The isolated particle will now undergo pre-clinical safety and efficacy.
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.